Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1741)	5/24/2001 5:04:10 PM
From: Ian@SI	Read Replies (2) \| Respond to of 2344

Bernard, If you do listen; and if you listen to Alex's answer to the first Q in the Q&A, I'd be interested in your interpretation of that answer. A shareholder asks about the probability of an early NDA filing with the FDA. Alex finishes the answer with "I'm quite confident." But I'm not sure whether he's quite confident in the ultimate success of Theratope; or, if he's confident that a successful NDA will be filed early. I think we're now too close to significant events to be out of the stock. With Merck's financial and regulatory backing, as well as their marketing and sales strengths, several risks have been sharply reduced if not removed altogether. IMO, RAGL, Ian.